Summary
Fulcrum Therapeutics, Inc.
Founded in 2016
Description
Modulating gene expression to treat the root cause of genetically defined diseases. Learn more about our pipeline and our culture.
Strengths
- Fulcrum Therapeutics, Inc. has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Fulcrum Therapeutics, Inc. was founded, the company has grown faster than the industry average
- Employees are staying with the company and less likely to churn compared to the rest of the industry
Weaknesses
- Variance of revenue growth is more than the industry average
- Web traffic rankings are worse than the industry average
Annual Revenue
Fulcrum Therapeutics, Inc.'s annual revenue
$16966000
Based on Kona Equity data
-
Revenue per employee
$163134
-
Variance of revenue growth
353.99
-
Annual revenue growth since founding
$2120750
-
Revenue growth rate from first known quarter to current
624.8%
Employee Count
104 employees
-
Employee growth rate from first known quarter to current
329.4%
-
Current employees on Linkedin
92
-
Churned employees
52
-
Churn rate percentage
56.52%
Executives
Ayla Ergun
Senior Principal Computational Biologist
a**@fulcrumtx.comMel Okan
Chief Commercial Officer CCO
m**@fulcrumtx.comKristine Castiglia
Administrative Coordinator
k**@fulcrumtx.comJoshua Wong
Associate Systems Engineer
j**@fulcrumtx.comScott Morrison
Executive Vice President & Client Partner
s**@fulcrumtx.comMelvin Hayner
Chief Commercial Officer CCO
m**@fulcrumtx.comWilna Krekorian
Program Project Administrator
w**@fulcrumtx.comGregory Tourangeau
Director, Controller
g**@fulcrumtx.comSandeepraj Pusalkar
Scientist II
s**@fulcrumtx.comJesus Rodriguez
Senior Manager, Clinical Quality Assurance
j**@fulcrumtx.comGenevieve Wilson
Scientist II, Muscle Biology
g**@fulcrumtx.comMel Felio
Chief Commercial Officer CCO
m**@fulcrumtx.comGeoffrey Allen
Vice President Hematology, BD
g**@fulcrumtx.comKelly Marshall
Senior Manager, Clinical Operations
k**@fulcrumtx.comLorin Thompson
Senior Director, Molecular Sciences
l**@fulcrumtx.comJacob Siegel
Research Intern
j**@fulcrumtx.comLee Hawkes
Executive Coordinator
l**@fulcrumtx.comEsther Rajavelu
Chief Financial Officer
e**@fulcrumtx.comCurtis Oltmans
Senior Vice President and General Counsel
c**@fulcrumtx.comMel Hayes
Chief Commercial Officer
m**@fulcrumtx.comDee Smith
Executive Director, Corporate Communications
d**@fulcrumtx.comKrista Gipson
Scientist I
k**@fulcrumtx.comPeter Thomson
Vice President, Finance & Accounting
p**@fulcrumtx.comJoann Walters
Administrative Assistant
j**@fulcrumtx.comJudith Dunn
President, Research & Development
j**@fulcrumtx.comSwathi Srivatsa
Corporate Strategy Director, Product Planning
s**@fulcrumtx.comPalak Shah
Research Associate
p**@fulcrumtx.comBryan Stuart
CEO
b**@fulcrumtx.comKim Stickland
Vice President
k**@fulcrumtx.comPhone Therapeutics
President & Chief Executive Officer
p**@fulcrumtx.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
- G8 LinkedIn Churn is lower than the industry average.
Web Analysis
-
Rank
2.55 M
-
Page views per visitor
2.0
-
Daily time
1:24
-
Bounce Rate
40.0 %
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: Fulcrum Therapeutics, Inc.
- Category: Biotechnology
- Industry: Biotechnology Company
- SIC: 87; 873
- NAICS: 561499; 5417
See similar companies
-
By City Cambridge Small Biotechnology Company in Cambridge Mid-size Biotechnology Company in Cambridge Biotechnology in Cambridge Small Biotechnology in Cambridge Mid-size Biotechnology in Cambridge
-
By State MA Small companies in MA Biotechnology in MA Small Biotechnology in MA Mid-size Biotechnology in MA Small Biotechnology Company in MA Mid-size Biotechnology Company in MA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Biotechnology and Biotechnology Company
-
Firmographic data G Score of 6 Founded in 2016 SIC: 87 SIC: 873 NAICS: 561499 NAICS: 5417 #Education General #Organizations General #Education #Organizations
Frequently Asked Questions
Fulcrum Therapeutics, Inc.'s headquarters are located at 26 LANDSDOWNE St. Building 700, Suite B7102 Cambridge, MA 02139.
Fulcrum Therapeutics, Inc.'s official website is fulcrumtx.com
Fulcrum Therapeutics, Inc.'s annual revenue is $17.0 M.
Fulcrum Therapeutics, Inc.'s SIC: 87; 873
Fulcrum Therapeutics, Inc.'s NAICS: 561499; 5417.
Fulcrum Therapeutics, Inc. has 104 employees
Fulcrum Therapeutics, Inc. is in the industry of Biotechnology.